R-GDP Regimen - CISMeF

Preferred Label : R-GDP Regimen;

NCIt synonyms : GDP Plus RITU Regimen; Gemcitabine-Dexamethasone-Platinol-Rituximab; Rituximab/Gemcitabine/Dexamethasone/Cisplatin; GDP-R Regimen; GDP/Rituximab; Cisplatin/Dexamethasone/Gemcitabine/Rituximab;

NCIt related terms : R-GDP; R-GDP (rituximab-blit); R-GDP (rituximab-arrx); R-GDP (rituximab-rite); R-GDP (rituximab-rixi); R-GDP (rituximab-rixa); R-GDP (rituximab-abbs); R-GDP (rituximab-pvvr);

NCIt definition : A regimen consisting of rituximab, gemcitabine, dexamethasone and cisplatin that can be used in the treatment of Hodgkin lymphoma (HL), Burkitt lymphhoma, and diffuse large B-cell lymphoma.;

NCI Metathesaurus CUI : CL538183;

Codes from synonyms : 16336; 128738; 128110; 127796; 128424; 127953; 128581; 128267;

Détails

Origin ID

C140101;

UMLS CUI

C4682702;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cisplatin [NCIt concept]
- Dexamethasone [NCIt concept]
- Gemcitabine Hydrochloride [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients